Skip to main content
Erschienen in: Acta Diabetologica 9/2019

09.04.2019 | Case Report

Extreme hyperosmolarity and severe ketoacidosis in a child with type 1 diabetes mellitus at onset safely treated with current guidelines

verfasst von: G. Tonti, G. Maltoni, A. Cassio, S. Zucchini

Erschienen in: Acta Diabetologica | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Excerpt

Type 1 diabetes mellitus (T1DM) is an autoimmune disorder characterized by the destruction of pancreatic beta cells by autoantibodies resulting in low or no production of endogenous insulin. The incidence of T1DM is extremely variable depending on the countries, and it is progressively growing [1]. Ketoacidosis (DKA) is present at diagnosis in 15–70% of patients affected by T1DM and is more frequent in children younger than 2 years of age, in case of delayed diagnosis, in some ethnic minorities and in children with poor access to medical care for socio-economic reasons [1]. DKA is defined by the presence of hyperglycaemia (blood glucose > 200 mg/dL), venous pH < 7.3 or serum bicarbonate < 15 mmol/L, ketonemia (blood β-hydroxybutyrate ≥ 3 mmol/L) or moderate or large ketonuria. Clinically, it shows through dehydration, tachycardia, tachypnea, sighing (Kussmaul) respiration, nausea, vomiting, abdominal pain and confusion state up to coma [1]. The hyperglycaemic hyperosmolar state (HHS) is an uncommon condition in children, and it usually occurs in an obese adolescent with type 2 diabetes mellitus (T2DM). Criteria to define HHS are hyperglycaemia (blood glucose > 600 mg/dL), venous pH > 7.25 (arterial pH > 7.3), bicarbonate > 15 mmol/L, small ketonuria and absent or mild ketonemia, serum osmolarity > 320 mOsm/kg, altered mental status and severe dehydration [1]. HHS rarely represents the onset manifestation of T1DM [2]. Some cases of T1DM with an initial manifestation of a mixed state with both conditions (DKA-HHS) are described in the literature [3]. …
Literatur
1.
Zurück zum Zitat Wolfsdorf JI, Glaser N, Agus M et al (2018) ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 19(Suppl. 27):155–177CrossRef Wolfsdorf JI, Glaser N, Agus M et al (2018) ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 19(Suppl. 27):155–177CrossRef
2.
Zurück zum Zitat Wetter J, Gohlke BC, Woelfle JF (2012) Hyperglycemic hyperosmolar state as initial manifestation of pediatric insulin-dependent diabetes. Klin Padiatr 224:32–33CrossRef Wetter J, Gohlke BC, Woelfle JF (2012) Hyperglycemic hyperosmolar state as initial manifestation of pediatric insulin-dependent diabetes. Klin Padiatr 224:32–33CrossRef
3.
Zurück zum Zitat Viswanathan V, Beardsley AL, Walvood EC, Nebesio TD (2011) Extreme hyperglycemia and hyperosmolar state in new onset type 1 diabetes: are sugar- and salt-containing beverages at fault? Clin Pediatr (Phila) 50(4):360–363CrossRef Viswanathan V, Beardsley AL, Walvood EC, Nebesio TD (2011) Extreme hyperglycemia and hyperosmolar state in new onset type 1 diabetes: are sugar- and salt-containing beverages at fault? Clin Pediatr (Phila) 50(4):360–363CrossRef
4.
Zurück zum Zitat Kuppermann N, Ghetti S, Schunk JE et al (2018) Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med 378(24):2275–2287CrossRef Kuppermann N, Ghetti S, Schunk JE et al (2018) Clinical trial of fluid infusion rates for pediatric diabetic ketoacidosis. N Engl J Med 378(24):2275–2287CrossRef
5.
Zurück zum Zitat Lawrence SE, Cummings EA, Gaboury I, Daneman D (2005) Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr 146:688–692CrossRef Lawrence SE, Cummings EA, Gaboury I, Daneman D (2005) Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr 146:688–692CrossRef
Metadaten
Titel
Extreme hyperosmolarity and severe ketoacidosis in a child with type 1 diabetes mellitus at onset safely treated with current guidelines
verfasst von
G. Tonti
G. Maltoni
A. Cassio
S. Zucchini
Publikationsdatum
09.04.2019
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 9/2019
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-019-01336-3

Weitere Artikel der Ausgabe 9/2019

Acta Diabetologica 9/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.